Pacific Hospital Supply Co., Ltd (4126.TWO)
TWD 91.6
(0.99%)
TWD 91.6
(0.99%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 420.79 Million TWD | 26.98% |
| 2022 | 331.39 Million TWD | -14.24% |
| 2021 | 386.41 Million TWD | 17.55% |
| 2020 | 328.72 Million TWD | -28.4% |
| 2019 | 459.12 Million TWD | 112.21% |
| 2018 | 216.35 Million TWD | -8.75% |
| 2017 | 237.09 Million TWD | -28.73% |
| 2016 | 332.66 Million TWD | -5.31% |
| 2015 | 351.3 Million TWD | 7.44% |
| 2014 | 326.98 Million TWD | 1.58% |
| 2013 | 321.89 Million TWD | 2.69% |
| 2012 | 313.46 Million TWD | -3.04% |
| 2011 | 323.28 Million TWD | -6.0% |
| 2010 | 343.92 Million TWD | 2806.57% |
| 2009 | -12.7 Million TWD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 99.82 Million TWD | -7.27% |
| 2024 Q1 | 107.65 Million TWD | 47.65% |
| 2023 FY | 420.79 Million TWD | 26.98% |
| 2023 Q4 | 72.91 Million TWD | -41.12% |
| 2023 Q3 | 123.82 Million TWD | 12.06% |
| 2023 Q2 | 110.49 Million TWD | -2.7% |
| 2023 Q1 | 113.56 Million TWD | 9.53% |
| 2022 Q2 | 58.8 Million TWD | 5.08% |
| 2022 Q4 | 103.67 Million TWD | -8.21% |
| 2022 FY | 331.39 Million TWD | -14.24% |
| 2022 Q1 | 55.96 Million TWD | 38.34% |
| 2022 Q3 | 112.94 Million TWD | 92.06% |
| 2021 Q1 | 86 Million TWD | 7.15% |
| 2021 Q3 | 205.66 Million TWD | 278.84% |
| 2021 Q4 | 40.45 Million TWD | -80.33% |
| 2021 FY | 386.41 Million TWD | 17.55% |
| 2021 Q2 | 54.28 Million TWD | -36.88% |
| 2020 Q1 | 66.02 Million TWD | -70.57% |
| 2020 Q4 | 80.27 Million TWD | -2.96% |
| 2020 Q3 | 82.72 Million TWD | -17.03% |
| 2020 FY | 328.72 Million TWD | -28.4% |
| 2020 Q2 | 99.7 Million TWD | 51.0% |
| 2019 Q2 | 91.42 Million TWD | 52.83% |
| 2019 Q4 | 224.38 Million TWD | 168.76% |
| 2019 FY | 459.12 Million TWD | 112.21% |
| 2019 Q1 | 59.82 Million TWD | -14.75% |
| 2019 Q3 | 83.49 Million TWD | -8.68% |
| 2018 FY | 216.35 Million TWD | -8.75% |
| 2018 Q4 | 70.16 Million TWD | 4.4% |
| 2018 Q3 | 67.2 Million TWD | 60.62% |
| 2018 Q2 | 41.84 Million TWD | 12.69% |
| 2018 Q1 | 37.13 Million TWD | -10.11% |
| 2017 Q4 | 41.3 Million TWD | -47.97% |
| 2017 FY | 237.09 Million TWD | -28.73% |
| 2017 Q2 | 55.45 Million TWD | -9.0% |
| 2017 Q1 | 60.94 Million TWD | 1.37% |
| 2017 Q3 | 79.38 Million TWD | 43.16% |
| 2016 Q2 | 90.49 Million TWD | -12.86% |
| 2016 Q3 | 78.2 Million TWD | -13.58% |
| 2016 FY | 332.66 Million TWD | -5.31% |
| 2016 Q4 | 60.11 Million TWD | -23.13% |
| 2016 Q1 | 103.85 Million TWD | -9.35% |
| 2015 Q3 | 121.59 Million TWD | 157.65% |
| 2015 FY | 351.3 Million TWD | 7.44% |
| 2015 Q1 | 67.95 Million TWD | -35.84% |
| 2015 Q4 | 114.56 Million TWD | -5.78% |
| 2015 Q2 | 47.19 Million TWD | -30.55% |
| 2014 Q1 | 85.3 Million TWD | 24.46% |
| 2014 Q3 | 78.74 Million TWD | 38.09% |
| 2014 FY | 326.98 Million TWD | 1.58% |
| 2014 Q4 | 105.91 Million TWD | 34.5% |
| 2014 Q2 | 57.02 Million TWD | -33.15% |
| 2013 Q1 | 92.55 Million TWD | 18.5% |
| 2013 Q3 | 70.91 Million TWD | -21.11% |
| 2013 Q4 | 68.53 Million TWD | -3.35% |
| 2013 FY | 321.89 Million TWD | 2.69% |
| 2013 Q2 | 89.88 Million TWD | -2.89% |
| 2012 FY | 313.46 Million TWD | -3.04% |
| 2012 Q4 | 78.1 Million TWD | -7.92% |
| 2012 Q3 | 84.82 Million TWD | 11.31% |
| 2012 Q2 | 76.2 Million TWD | 1.4% |
| 2012 Q1 | 75.15 Million TWD | 22.34% |
| 2011 Q1 | 81.39 Million TWD | 7.13% |
| 2011 FY | 323.28 Million TWD | -6.0% |
| 2011 Q4 | 61.43 Million TWD | -24.12% |
| 2011 Q3 | 80.95 Million TWD | -18.64% |
| 2011 Q2 | 99.5 Million TWD | 22.25% |
| 2010 Q1 | 100.74 Million TWD | 0.0% |
| 2010 FY | 343.92 Million TWD | 2806.57% |
| 2010 Q2 | 84.79 Million TWD | -15.83% |
| 2010 Q4 | 75.97 Million TWD | -7.8% |
| 2010 Q3 | 82.4 Million TWD | -2.81% |
| 2009 FY | -12.7 Million TWD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| St.Shine Optical Co.,Ltd. | 545.95 Million TWD | 22.925% |
| Bioteque Corporation | 452.55 Million TWD | 7.018% |
| Chi Sheng Pharma & Biotech Co., Ltd | 68.67 Million TWD | -512.738% |
| Sunder Biomedical Tech. Co., Ltd. | -33.15 Million TWD | 1369.166% |
| BenQ Medical Technology Corporation | 114.58 Million TWD | -267.244% |
| Unicon Optical Co., Ltd. | 207.73 Million TWD | -102.559% |
| Formosa Optical Technology Co.,Ltd. | 417.94 Million TWD | -0.682% |
| Medeon Biodesign, Inc. | -1.2 Billion TWD | 134.932% |
| Concord Medical Co., Ltd. | 42.74 Million TWD | -884.447% |
| Crystalvue Medical Corporation | 103.39 Million TWD | -306.971% |
| Perfect Medical Industry Co., Ltd. | 40.08 Million TWD | -949.645% |
| ICARES Medicus, Inc. | 97.72 Million TWD | -330.57% |
| Lagis Enterprise Co., Ltd. | 64.1 Million TWD | -556.411% |
| Amed Co., Ltd. | 91.71 Million TWD | -358.799% |